 |
|
|
An analyst and top management from 10 sector firms examine the Drug Delivery sector in this 47 page report from The Wall Street Transcript. |
 |
- Specialty Pharmaceuticals & Drug Delivery: Louis Webb, WR Hambrecht & Co
- Off the Record: Off the Record asks company leadership which management teams in their sector they most respect for their ability to execute and generate shareholder value.
- CEO Interviews (average 2,500 words): Top management from 10 sector firms examine the outlook for their firm and the sector. Firms interviewed include: ADVENTRX Pharmaceuticals, Aerogen, BioDelivery Sciences International, Carrington Laboratories, CytRx Corporation, Delcath Systems, DOR BioPharma, NovaDel Pharma Inc. and Vical Incorporated.
Topics covered: Technology assessment | Role of therapeutics | R&D monitoring | Chiral chemistry | Anti-insomnia market | Visualization agents in MRI | Diabetes market | Stock picks
Companies covered: Sepracor, Inc. (SEPR), EPIX Medical (EPIX), Nektar Therapeutics (NKTR), Pharmaceuticals, Inc. (KG), EPIX Medical, Schering AG (SHR).
This Issue costs $175 - and is non-returnable.
The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.
|
 |

Investors and Industry Execs.
The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best.
Money manager interviews provide the view from the buy-side.
CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.
Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.
Sincerely,
Andrew Pickup
Publisher
|
|
 |